Bridgewater Associates’s Argan AGX Stock Holding History

Bridgewater Associates’s Portfolio AGX Stock Details AGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.03M	Sell	10,050 -3,939	-28%	-$2.62M	0.03%	375
2026 Q1	$7.62M	Buy	+13,989	New	+$5.7M	0.03%	319

Other funds holding AGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return

Bridgewater Associates's AGX Position: Q2 2026 in Review

Bridgewater Associates reduced its Argan (AGX) stake by 28% in Q2 2026, selling an estimated $2.62M and leaving 10,050 shares worth $8.03M. The position accounts for 0.03% of the portfolio, ranked #375.

Bridgewater Associates first reported a position in AGX in Q1 2026 and has held it in 2 quarters since. 562 funds tracked by Wall St. Rank hold AGX as of Q2 2026.

Bridgewater Associates held 10,050 shares of Argan worth $8.03M as of Q2 2026.
Bridgewater Associates sold 3,939 Argan shares in Q2 2026, an estimated $2.62M.
Argan made up 0.03% of Bridgewater Associates's portfolio in Q2 2026, its #375 holding.
Bridgewater Associates first reported a position in Argan in Q1 2026 and has held it in 2 quarters since.
562 funds tracked by Wall St. Rank held Argan as of Q2 2026.

Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.